Oncology is the branch of medicine that deals with the diagnosis and treatment of cancer. Oncologists are medical doctors who specialize in the care of patients with cancer. They work closely with other healthcare professionals, such as radiation therapists and nurses, to provide comprehensive care for patients with cancer.
The main goal of oncology is to diagnose cancer as early as possible and provide treatment that will eradicate the cancer or prolong the patient’s life. The treatment of cancer typically involves a combination of surgery, radiation therapy, and chemotherapy. In recent years, immunotherapy and targeted therapy have also been used in cancer treatment.
Oncologists also play an important role in providing emotional and psychological support to cancer patients and their families. They often work with a team of specialists to provide patient-centered care that addresses the physical, emotional, and social needs of the patient.
As cancer is a complex disease and treatments are continuously evolving, oncology is a fast-paced field that requires ongoing learning and adaptation. Also, cancer disproportionately affects elderly population and people with comorbidities, so oncology care is often delivered in coordination with other medical and surgical specialties.
Know anyone building innovative solutions that belong in this 'Oncology'?
Scientex Conferences is delighted to welcome you all to the 3rd International Conference on Oncology Research and Treatment which is slated to hold from November 30-December 01, 2023 in Dubai, UAE organized under the theme “The Advancements in Oncology Research & Treatment”.
Oncology 2023 aims to highlight the technological application experiences and to provide opportunities for discussion and information sharing platforms for scientists from various organizations, universities, institutes, laboratories, associations, societies, and industrialists regarding their findings, technology, policies, and services.
Oncology Conference is designed to disseminate the most recent research findings and progresses in the Oncology, Research area to society. These fields have become high concerns to the public and private sectors, researchers, academicians, and industrialists.
With strong effectiveness profiles and 20 years of FDA approval, kinase inhibitors have revolutionized oncology treatment. The success of current kinase inhibitor classes is nevertheless constrained by rising resistance and security concerns.
The 2nd Next Generation Kinase Inhibitors Summit is the only industry-focused conference devoted to using novel kinase biology in drug development and innovating current programs to produce the next generation of kinase inhibitor drugs that can demonstrate effective and long-lasting clinical responses in oncology and other fields.
The 2023 Clinical Hematology and Oncology Conference, presented by Scripps MD Anderson Cancer Center, is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts in diverse areas of hematology and oncology, affording them an intimate environment in which to discuss new clinical developments and significant advances.
February 18 to February 20, 2023
Hyatt Regency La Jolla At Aventine, 3777 La Jolla Village Drive, San Diego, California, 92122, United States
The event will feature state of the art advances in oncology treatment delivered through an expert panel of University of Chicago Medicine faculty and regional experts from the Gulf Region.
This conference will provide attendees with the ideal forum to learn and discuss the latest ﬁndings in treatment of cancer patients to improve the outcomes for patients with cancer, which is still one of the biggest challenges of the 21st century.
The 7th Liquid Biopsy for Precision Oncology Summit returns as the largest and most comprehensive forum for all stakeholders in the field to tap into the promising opportunities that revolutionize the entire cancer patient care continuum from early translation all the way through to clinical development and commercialization.
Expect exclusive data from KOLs on the most recent developments in the utilization of liquid biopsies for early detection, prognosis and treatment. Join 200+ pioneers from the likes of Pfizer, AstraZeneca, BloodPAC, NuProbe and many more as we explore key scientific, technical, regulatory and commercial challenges associated with progressing precision oncology pipelines harnessing liquid biopsies.
Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology.
In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.
From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.
Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time - don't miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!
Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.
This conference is for both General Pediatricians and Pediatric Hematologists and Oncologists. We aim to emphasize on the early detection and diagnosis of common hematological and oncological problems in children and to discuss their management by both the general practitioner and the specialist.
We are delighted to present renowned experts from the UAE and abroad. The focus will be on interaction and exchange of ideas, knowledge and experience that will enable best possible care for children. We believe the event will be of interest to General Pediatricians, Pediatric Subspecialists, Pediatric Trainees, Residents and Fellows, Family Physicians, General Practitioners, and Emergency Medicine Physicians.
The event will also provide an opportunity for networking for future academic and clinical collaborations. we look forward to your participation and trust this will be a unique educational experience.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our